| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010903 |
| Receipt No. | R000012758 |
| Official scientific title of the study | An Evaluation of Kyorin Cardiovascular Perioperative Screening for Non-Cardiac Surgery |
| Date of disclosure of the study information | 2013/08/01 |
| Last modified on | 2016/06/07 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | An Evaluation of Kyorin Cardiovascular Perioperative Screening for Non-Cardiac Surgery | |
| Title of the study (Brief title) | KCPS study | |
| Region |
|
|
| Condition | |||||
| Condition | Non cardiac surgery | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To evaluate the advantage of peri-operative screening for non cardiac surgery based on the guideline of ACC/AHA guidelines. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Cardiac death, Sudden death of unknown reason |
| Key secondary outcomes | Non cardiac death, Non fatal myocardial infarction, Hospitalization for unstable angina, Stroke, Receiving PCI or CABG |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients over 20 years old receiving general anethesia and non cardiac surgery in Kyorin university hospital | |||
| Key exclusion criteria | Patients under 19 years old | |||
| Target sample size | 5000 | |||
| Research contact person | |
| Name of lead principal investigator | Hideaki Yoshino |
| Organization | Kyorin University School of Medicine |
| Division name | Second Internal Medicine |
| Address | 20-2 Shinkawa6 Mitaka Tokyo 181-8611 JAPAN |
| TEL | 0422-47-5511 |
| yoshino@kskyorin-u.ac.jp | |
| Public contact | |
| Name of contact person | Seiichi Taniai |
| Organization | Kyorin University School of Medicine |
| Division name | Second department of Internal Medicine |
| Address | 20-2 Shinkawa6 Mitaka Tokyo 181-8611 JAPAN |
| TEL | 0422-47-5511 |
| Homepage URL | |
| tanny@ks.kyorin-u.ac.jp | |
| Sponsor | |
| Institute | Kyorin University School of Medicine, Second department of Internal Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Kyorin University School of Medicine, Second department of Internal Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 杏林大学医学部付属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | We reported the experience and usefulness of Kyorin cardiac perioperative screening for non-cardiacsurgery with the data of 237 patients at the 58th Annual Scientific Session of the Japanese College of Cardiology |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012758 |